ID 212 - Witamina B12

PL: Witamina B12
EN: Vitamin B12
Pdf: various food(s)/food constituent(s) that are referring to children’s development

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claims is vitamin B12, which is a specific group of cobalt-containing corrinoids with biological activity in humans. Recommended biochemical nomenclature restricts the term vitamin B12 for the particular form of cobalamin known as cyanocobalamin and all cobalamins exhibiting qualitatively the biological activity of cyanocobalamin. Cobalamins do not occur in plants but are synthesised by certain bacteria, fungi and algae, which constitute the ultimate source of all cobalamin found in nature (Green, 2005). Vitamin B12 is a well recognised nutrient and is measurable in foods by established methods.
Vitamin B12 occurs naturally in foods and is authorised for addition to foods and for use in food supplements (Annex I of the Regulation (EC) No 1925/20066 and Annex I of Directive 2002/46/EC7). This evaluation applies to vitamin B12 naturally present in foods and those forms authorised for addition to foods (Annex II of the Regulation (EC) No 1925/2006 and Annex II of Directive 2002/46/EC).
The Panel considers that the food constituent, vitamin B12, which is the subject of the health claims, is sufficiently characterised.

2.9. Podziały komórek (ID 212)

The claimed effect is “supports folic acid metabolism, in succession: DNA synthesis”. The Panel assumes that the target population is the general population.
In the context of the clarifications provided by Member States, the Panel assumes that the claimed effect is related to cell division.
A claim on vitamin B12 and normal cell division has already been assessed with a favourable outcome (EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2009).

5. Warunki i możliwe ograniczenia stosowania oświadczenia

The Panel considers that in order to bear the claims a food should be at least a source of vitamin B12 as per Annex to Regulation (EC) No 1924/2006. Such amounts can be easily consumed as part of a balanced diet. The target population is the general population. For vitamin B12 no adverse effects have been reported after high dose supplementation and no Tolerable Upper Intake Levels (ULs) have been set (SCF, 2000).

Warunki i możliwe ograniczenia stosowania oświadczenia

yes